Pro Share Advisors LLC Catalent, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 28,325 shares of CTLT stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,325
Previous 30,395 6.81%
Holding current value
$1.8 Million
Previous $1.71 Million 0.35%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$56.16 - $60.96 $116,251 - $126,187
-2,070 Reduced 6.81%
28,325 $1.72 Million
Q2 2024

Aug 13, 2024
BUY
$53.58 - $57.02 $87,442 - $93,056
1,632 Added 5.67%
30,395 $1.71 Million
Q1 2024

May 08, 2024
BUY
$42.56 - $59.82 $162,323 - $228,153
3,814 Added 15.29%
28,763 $1.62 Million
Q4 2023

Feb 14, 2024
SELL
$32.18 - $46.57 $87,368 - $126,437
-2,715 Reduced 9.81%
24,949 $1.12 Million
Q3 2023

Nov 13, 2023
SELL
$44.2 - $50.2 $52,553 - $59,687
-1,189 Reduced 4.12%
27,664 $1.26 Million
Q2 2023

Aug 10, 2023
BUY
$31.86 - $67.26 $15,611 - $32,957
490 Added 1.73%
28,853 $1.25 Million
Q1 2023

May 11, 2023
BUY
$45.44 - $74.26 $182,350 - $298,005
4,013 Added 16.48%
28,363 $1.86 Million
Q4 2022

Feb 02, 2023
SELL
$41.39 - $81.0 $1,779 - $3,483
-43 Reduced 0.18%
24,350 $1.1 Million
Q3 2022

Nov 04, 2022
SELL
$72.36 - $113.1 $201,450 - $314,870
-2,784 Reduced 10.24%
24,393 $1.76 Million
Q2 2022

Aug 01, 2022
SELL
$87.2 - $114.05 $1.1 Million - $1.44 Million
-12,639 Reduced 31.74%
27,177 $2.92 Million
Q1 2022

May 10, 2022
BUY
$94.19 - $124.49 $66,027 - $87,267
701 Added 1.79%
39,816 $4.42 Million
Q4 2021

Feb 08, 2022
BUY
$119.57 - $139.07 $1.01 Million - $1.18 Million
8,469 Added 27.63%
39,115 $5.01 Million
Q3 2021

Nov 12, 2021
SELL
$109.17 - $142.35 $987,224 - $1.29 Million
-9,043 Reduced 22.78%
30,646 $4.08 Million
Q2 2021

Aug 13, 2021
BUY
$100.34 - $115.69 $454,038 - $523,497
4,525 Added 12.87%
39,689 $4.29 Million
Q1 2021

May 14, 2021
BUY
$101.51 - $125.27 $134,094 - $165,481
1,321 Added 3.9%
35,164 $3.7 Million
Q4 2020

Feb 09, 2021
BUY
$85.88 - $105.36 $1.16 Million - $1.43 Million
13,551 Added 66.78%
33,843 $3.52 Million
Q3 2020

Nov 13, 2020
BUY
$72.74 - $92.5 $510,562 - $649,257
7,019 Added 52.88%
20,292 $1.74 Million
Q2 2020

Aug 03, 2020
BUY
$48.02 - $79.04 $228,671 - $376,388
4,762 Added 55.95%
13,273 $973,000
Q1 2020

May 15, 2020
SELL
$36.95 - $62.95 $273,393 - $465,767
-7,399 Reduced 46.51%
8,511 $442,000
Q4 2019

Feb 12, 2020
BUY
$47.06 - $56.64 $69,272 - $83,374
1,472 Added 10.2%
15,910 $896,000
Q3 2019

Nov 12, 2019
SELL
$47.45 - $58.05 $33,309 - $40,751
-702 Reduced 4.64%
14,438 $688,000
Q2 2019

Aug 13, 2019
SELL
$39.26 - $54.21 $109,260 - $150,866
-2,783 Reduced 15.53%
15,140 $821,000
Q1 2019

May 15, 2019
BUY
$29.84 - $43.92 $118,673 - $174,669
3,977 Added 28.52%
17,923 $727,000
Q4 2018

Feb 14, 2019
SELL
$29.95 - $46.34 $94,761 - $146,619
-3,164 Reduced 18.49%
13,946 $435,000
Q3 2018

Nov 14, 2018
BUY
$40.12 - $45.55 $101,824 - $115,605
2,538 Added 17.42%
17,110 $779,000
Q2 2018

Aug 13, 2018
SELL
$38.72 - $42.52 $667,300 - $732,789
-17,234 Reduced 54.18%
14,572 $610,000
Q1 2018

May 14, 2018
SELL
$39.4 - $47.39 $125,922 - $151,458
-3,196 Reduced 9.13%
31,806 $1.31 Million
Q4 2017

Feb 14, 2018
BUY
$37.27 - $43.02 $570,790 - $658,851
15,315 Added 77.79%
35,002 $1.44 Million
Q3 2017

Nov 13, 2017
SELL
$33.75 - $41.67 $94,095 - $116,175
-2,788 Reduced 12.4%
19,687 $786,000
Q2 2017

Aug 11, 2017
BUY
N/A
22,475
22,475 $789,000

Others Institutions Holding CTLT

# of Institutions
514
Shares Held
149M
Call Options Held
575K
Put Options Held
2.03M
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email